US5470876A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Topical sod for treating hair loss
Assignee: Individual
•
Filing: 1994-04-18
•
Granted: 1995-11-28
•
Expires: 2014-04-18
Abstract
Abstract SOD for treating hair loss is disclosed. The SOD has utility in a topical pharmaceutical formulation for the cosmetic treatment of hair loss and the cosmetic stimulation of hair growth. The SOD comprises copper salicylate, copper aspirinate, indomethacin-copper, or a complex of an amino acid or peptide and a transition metal.
Inventors
- 👤 Peter H. Proctor
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 12:57
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/49; A61K31/00; A61K31/33; A61K31/335; A61K31/365; A61K31/375; A61K31/395; A61K31/41; A61K31/4164; A61K31/4166; A61K8/46; A61K8/494; A61K8/4953; A61K8/63; A61K8/67; A61K8/676; A61Q; A61Q5/00; A61Q5/02; A61Q7/00; A61K2800/00; A61K2800/40; A61K2800/58
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
63 words
A method for stimulating hair growth comprising the step of: applying in a topical pharmaceutical carrier to skin a transition metal compound having SOD activity, said compound selected from copper salicylate, copper aspirinate, indomethacin-copper and a complex of an amino acid or peptide and a transition metal, wherein the peptide consists of amino acids selected from glycine, histidine, lysine, arginine, cysteine or methionine.
Claim 2
Independent Claim
63 words
A method for stimulating hair growth comprising the step of: applying in a topical pharmaceutical carrier to skin a transition metal compound having SOD activity, said compound selected from copper salicylate, copper aspirinate, indomethacin-copper and a complex of an amino acid or peptide and a transition metal, wherein the peptide consists of amino acids selected from glycine, histidine, lysine, arginine, cysteine or methionine.
Claim 3
Dependent Claim
35 words
The method of claim 1, wherein the amino acid of the amino acid-metal complex is selected from glycine, histidine, lysine, arginine, cysteine and methionine, and the metal is selected from copper, iron, zinc and manganese.
Claim 4
Dependent Claim
22 words
The method of claim 1, wherein the peptide is selected from histidyl lysine, glycyl histidine, glycyl hystidyl lysine and lysyl histidyl lysine.
Claim 5
Dependent Claim
13 words
The method of claim 1, wherein the transition metal compound is copper salicylate.
Claim 6
Dependent Claim
13 words
The method of claim 1, wherein the transition metal compound is copper aspirinate.
Claim 7
Dependent Claim
12 words
The method of claim 1, wherein the transition metal compound is indomethacin-copper.
Claim 8
Dependent Claim
50 words
a composition suitable for treating hair loss, comprising: a transition metal compound having SOD activity selected from copper salicylate, copper aspirinate, indomethacin-copper, and a complex of a basic amino acid and a transition metal; and a topical pharmaceutical carrier selected from oil and water emulsions, urea, propanol, butanol and glycols.
Claim 9
Dependent Claim
50 words
a composition suitable for treating hair loss, comprising: a transition metal compound having SOD activity selected from copper salicylate, copper aspirinate, indomethacin-copper, and a complex of a basic amino acid and a transition metal; and a topical pharmaceutical carrier selected from oil and water emulsions, urea, propanol, butanol and glycols.
Claim 10
Dependent Claim
30 words
The composition of claim 7, wherein the amino acid is selected from glycine, histidine, lysine, arginine, cysteine and methionine, and the metal is selected from copper, iron, zinc and manganese.
Claim 11
Dependent Claim
13 words
The composition of claim 7, wherein the transition metal compound is copper salicylate.
Claim 12
Dependent Claim
13 words
The composition of claim 7, wherein the transition metal compound is copper aspirinate.
Claim 13
Dependent Claim
12 words
The composition of claim 7, wherein the transition metal compound is indomethacin-copper.
Claim 14
Dependent Claim
48 words
A composition useful for treating hair loss, comprising: a transition metal compound of the formula R-M having superoxide dismutase activity wherein R is salicyl, acetylsalicyl or indomethacin, and M is copper, iron, zinc, or manganese; and a topical pharmaceutical carrier selected from creams, lotions, shampoos and cream rinses.
Claim 15
Dependent Claim
48 words
A composition useful for treating hair loss, comprising: a transition metal compound of the formula R-M having superoxide dismutase activity wherein R is salicyl, acetylsalicyl or indomethacin, and M is copper, iron, zinc, or manganese; and a topical pharmaceutical carrier selected from creams, lotions, shampoos and cream rinses.
Claim 16
Dependent Claim
9 words
The composition of claim 12, wherein R is salicyl.
Claim 17
Dependent Claim
9 words
The composition of claim 12, wherein R is acetylsalicyl.
Claim 18
Dependent Claim
9 words
The composition of claim 12, wherein R is indomethacin.
Claim 19
Dependent Claim
9 words
The composition of claim 12, wherein M is copper.
Claim 20
Dependent Claim
9 words
The composition of claim 12, wherein M is iron.
Claim 21
Dependent Claim
9 words
The composition of claim 12, wherein M is zinc.
Claim 22
Dependent Claim
9 words
The composition of claim 12, wherein M is manganese.
References Cited (Backward Citations)
US2409754A
Cited
US2986573A
Cited
US3257390A
Cited
US3461461A
Cited
US3527864A
Cited
US3551554A
Cited
US3896238A
Cited
US4367227A
Cited
US4139619A
Cited
US4596812A
Cited
US4184039A
Cited
US4254145A
Cited
US4327245A
Cited
EP0027655A2
Cited
US4344941A
Cited
US4456600A
Cited
US4444762A
Cited
WO1983002558A1
Cited
WO1984004922A1
Cited
WO1986000616A1
Cited
US4760051A
Cited
US5120831A
Cited
US5214032A
Cited
US4665054A
Cited
US5177061A
Cited
US4877770A
Cited
WO1987000427A1
Cited
EP0249397A2
Cited
GB2198132A
Cited
EP0273202B1
Cited
US4866067A
Cited
EP0327263B1
Cited
EP0415598A1
Cited
US5256678A
Cited
US5252559A
Cited
JPH0822644A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-11-27 | 1999-05-29 | 1999-11-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-11-27 | 2003-05-29 | 2003-11-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-11-27 | 2007-05-29 | 2007-11-28 | $7700.00 | Window Closed / Lapsed |